Christopher Melroy, MD
Otolaryngology · Savannah, GANPI 1659399368
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $256,150 of the $297,949 with a category attached, or 86.0%. GSK accounts for 98.8% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $96,589, more than ten times the $148 reported in 2019. Among otolaryngology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 360 payments — averaging $827.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$294K
- Aerin Medical Inc.$969
- Medtronic$950
- Regeneron Healthcare Solutions, Inc.$684
- Integra Lifesciences Corporation$239
- Acclarent, Inc$189
- plus $525 from 7 others
What the payments were for
- Speaking & faculty fees$256,15086%
- Travel & lodging$32,13011%
- Food & beverage$9,5053%
- Education$1640%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 296 | $294,393 |
| Aerin Medical Inc. | 11 | $969 |
| Medtronic | 1 | $950 |
| Regeneron Healthcare Solutions, Inc. | 27 | $684 |
| Integra Lifesciences Corporation | 6 | $239 |
| Acclarent, Inc | 6 | $189 |
| Sanofi | 6 | $184 |
| Neurent Medical Limited | 2 | $166 |
| Sanofi-aventis U.S. LLC | 1 | $68 |
| Amgen | 1 | $34 |
| Olympus America Inc. | 1 | $27 |
| Carestream Dental, LLC | 1 | $27 |
| Optinose US, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUCALA$290,558
- STRAIGHTSHOT$950
- VIVAER STYLUS$251
- RHINAER STYLUS$251
- VivAer$146
- RhinAer$146
- NEUROMARK Device$144
- NEUROMARK Radiofrequency Console$144
- DUPIXENT$105
How this compares
$297,949 in reported general payments places this provider in the 95th percentile of 308 otolaryngology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 18 | $67,396 |
| Ipratropium Bromide | 132 | $4,776 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 14 | $2,637 |
| CefuroximeCefuroxime Axetil | 38 | $639 |
| Fluticasone Propionate | 24 | $383 |
| Ondansetron OdtOndansetron | 37 | $321 |
| Montelukast Sodium | 15 | $240 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $182 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $149 |
| Mupirocin | 18 | $141 |
| Prednisone | 53 | $119 |
| Levocetirizine Dihydrochloride | 26 | $106 |
| Azelastine Hcl | 11 | $74 |
| Azithromycin | 12 | $61 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $59 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Savannah
- Robert LiebmanSavannah$4K
- Dozier HoodFayetteville$347K
- Karen HoffmannAtlanta$223K
- Jose StolovitzkyAtlanta$81K
- Jonathan LindmanEvans$55K
- Gregory PostmaAugusta$37K
- Oswaldo HenriquezSmyrna$15K
- Donald BrowningLawrenceville$14K
- Robert GadlageDuluth$14K
- Lawrence WeissMarietta$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.